Article Details
Retrieved on: 2018-03-18 23:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Dr. Schmidt will join Guggenheim from LEERINK Partners, where he has been an <b>equity</b> research analyst since 2009 and was named runner-up in the 2017 Institutional Investor All-America Research Survey in the Biotech/Mid- & Small-Cap category. Previous to joining LEERINK in 2009, he was a ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here